These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34447415)

  • 1. The Estimated Prevalence of N-Linked Congenital Disorders of Glycosylation Across Various Populations Based on Allele Frequencies in General Population Databases.
    Pajusalu S; Vals MA; Mihkla L; Šamarina U; Kahre T; Õunap K
    Front Genet; 2021; 12():719437. PubMed ID: 34447415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotypes and estimated prevalence of phosphomannomutase 2 deficiency in Turkey differ significantly from those in Europe.
    Yıldız Y; Arslan M; Çelik G; Kasapkara ÇS; Ceylaner S; Dursun A; Sivri HS; Coşkun T; Tokatlı A
    Am J Med Genet A; 2020 Apr; 182(4):705-712. PubMed ID: 31981409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Prevalence of PMM2-CDG in Estonia Based on Population Carrier Frequencies and Diagnosed Patients.
    Vals MA; Pajusalu S; Kals M; Mägi R; Õunap K
    JIMD Rep; 2018; 39():13-17. PubMed ID: 28685491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiomyopathy, an uncommon phenotype of congenital disorders of glycosylation: Recommendations for baseline screening and follow-up evaluation.
    Zemet R; Hope KD; Edmondson AC; Shah R; Patino M; Yesso AM; Berger JH; Sarafoglou K; Larson A; Lam C; Morava E; Scaglia F
    Mol Genet Metab; 2024 Jun; 142(4):108513. PubMed ID: 38917675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital disorders of glycosylation: Prevalence, incidence and mutational spectrum in the Polish population.
    Lipiński P; Bogdańska A; Tylki-Szymańska A
    Mol Genet Metab Rep; 2021 Jun; 27():100726. PubMed ID: 33643843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Analysis of Variants in the General Population Reveals That
    Citro V; Cimmaruta C; Monticelli M; Riccio G; Hay Mele B; Cubellis MV; Andreotti G
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30061496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frontiers in congenital disorders of glycosylation consortium, a cross-sectional study report at year 5 of 280 individuals in the natural history cohort.
    Lam C; Scaglia F; Berry GT; Larson A; Sarafoglou K; Andersson HC; Sklirou E; Tan QKG; Starosta RT; Sadek M; Wolfe L; Horikoshi S; Ali M; Barone R; Campbell T; Chang IJ; Coles K; Cook E; Eklund EA; Engelhardt NM; Freeman M; Friedman J; Fu DYT; Botzo G; Rawls B; Hernandez C; Johnsen C; Keller K; Kramer S; Kuschel B; Leshinski A; Martinez-Duncker I; Mazza GL; Mercimek-Andrews S; Miller BS; Muthusamy K; Neira J; Patterson MC; Pogorelc N; Powers LN; Ramey E; Reinhart M; Squire A; Thies J; Vockley J; Vreugdenhil H; Witters P; Youbi M; Zeighami A; Zemet R; Edmondson AC; Morava E
    Mol Genet Metab; 2024 Jun; 142(4):108509. PubMed ID: 38959600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic analysis of platelet N-glycoproteins in PMM2-CDG patients.
    de la Morena-Barrio ME; Di Michele M; Lozano ML; Rivera J; Pérez-Dueñas B; Altisent C; Sevivas T; Vicente V; Jaeken J; Freson K; Corral J
    Thromb Res; 2014 Mar; 133(3):412-7. PubMed ID: 24388574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A frequent mild mutation in ALG6 may exacerbate the clinical severity of patients with congenital disorder of glycosylation Ia (CDG-Ia) caused by phosphomannomutase deficiency.
    Westphal V; Kjaergaard S; Schollen E; Martens K; Grunewald S; Schwartz M; Matthijs G; Freeze HH
    Hum Mol Genet; 2002 Mar; 11(5):599-604. PubMed ID: 11875054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital disorders of glycosylation.
    Jaeken J
    Handb Clin Neurol; 2013; 113():1737-43. PubMed ID: 23622397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Insights into Immunological Involvement in Congenital Disorders of Glycosylation (CDG) from a People-Centric Approach.
    Francisco R; Pascoal C; Marques-da-Silva D; Brasil S; Pimentel-Santos FM; Altassan R; Jaeken J; Grosso AR; Dos Reis Ferreira V; Videira PA
    J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32635232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycomic Characterization of Induced Pluripotent Stem Cells Derived from a Patient Suffering from Phosphomannomutase 2 Congenital Disorder of Glycosylation (PMM2-CDG).
    Thiesler CT; Cajic S; Hoffmann D; Thiel C; van Diepen L; Hennig R; Sgodda M; Weiβmann R; Reichl U; Steinemann D; Diekmann U; Huber NM; Oberbeck A; Cantz T; Kuss AW; Körner C; Schambach A; Rapp E; Buettner FF
    Mol Cell Proteomics; 2016 Apr; 15(4):1435-52. PubMed ID: 26785728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical, laboratory and molecular findings and long-term follow-up data in 96 French patients with PMM2-CDG (phosphomannomutase 2-congenital disorder of glycosylation) and review of the literature.
    Schiff M; Roda C; Monin ML; Arion A; Barth M; Bednarek N; Bidet M; Bloch C; Boddaert N; Borgel D; Brassier A; Brice A; Bruneel A; Buissonnière R; Chabrol B; Chevalier MC; Cormier-Daire V; De Barace C; De Maistre E; De Saint-Martin A; Dorison N; Drouin-Garraud V; Dupré T; Echenne B; Edery P; Feillet F; Fontan I; Francannet C; Labarthe F; Gitiaux C; Héron D; Hully M; Lamoureux S; Martin-Coignard D; Mignot C; Morin G; Pascreau T; Pincemaille O; Polak M; Roubertie A; Thauvin-Robinet C; Toutain A; Viot G; Vuillaumier-Barrot S; Seta N; De Lonlay P
    J Med Genet; 2017 Dec; 54(12):843-851. PubMed ID: 28954837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repurposing the aldose reductase inhibitor and diabetic neuropathy drug epalrestat for the congenital disorder of glycosylation PMM2-CDG.
    Iyer S; Sam FS; DiPrimio N; Preston G; Verheijen J; Murthy K; Parton Z; Tsang H; Lao J; Morava E; Perlstein EO
    Dis Model Mech; 2019 Nov; 12(11):. PubMed ID: 31636082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic and genotypic spectrum of congenital disorders of glycosylation type I and type II.
    Al Teneiji A; Bruun TU; Sidky S; Cordeiro D; Cohn RD; Mendoza-Londono R; Moharir M; Raiman J; Siriwardena K; Kyriakopoulou L; Mercimek-Mahmutoglu S
    Mol Genet Metab; 2017 Mar; 120(3):235-242. PubMed ID: 28122681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver manifestations in a cohort of 39 patients with congenital disorders of glycosylation: pin-pointing the characteristics of liver injury and proposing recommendations for follow-up.
    Starosta RT; Boyer S; Tahata S; Raymond K; Lee HE; Wolfe LA; Lam C; Edmondson AC; Schwartz IVD; Morava E
    Orphanet J Rare Dis; 2021 Jan; 16(1):20. PubMed ID: 33413482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global serum glycoform profiling for the investigation of dystroglycanopathies & Congenital Disorders of Glycosylation.
    Heywood WE; Bliss E; Mills P; Yuzugulen J; Carreno G; Clayton PT; Muntoni F; Worthington VC; Torelli S; Sebire NJ; Mills K; Grunewald S
    Mol Genet Metab Rep; 2016 Jun; 7():55-62. PubMed ID: 27134828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital disorders of glycosylation.
    Chang IJ; He M; Lam CT
    Ann Transl Med; 2018 Dec; 6(24):477. PubMed ID: 30740408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Splicing Variant in the
    Slaba K; Noskova H; Vesela P; Tuckova J; Jicinska H; Honzik T; Hansikova H; Kleiblova P; Stourac P; Jabandziev P; Slaby O; Prochazkova D
    Front Genet; 2020; 11():561054. PubMed ID: 33133147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International clinical guidelines for the management of phosphomannomutase 2-congenital disorders of glycosylation: Diagnosis, treatment and follow up.
    Altassan R; Péanne R; Jaeken J; Barone R; Bidet M; Borgel D; Brasil S; Cassiman D; Cechova A; Coman D; Corral J; Correia J; de la Morena-Barrio ME; de Lonlay P; Dos Reis V; Ferreira CR; Fiumara A; Francisco R; Freeze H; Funke S; Gardeitchik T; Gert M; Girad M; Giros M; Grünewald S; Hernández-Caselles T; Honzik T; Hutter M; Krasnewich D; Lam C; Lee J; Lefeber D; Marques-de-Silva D; Martinez AF; Moravej H; Õunap K; Pascoal C; Pascreau T; Patterson M; Quelhas D; Raymond K; Sarkhail P; Schiff M; Seroczyńska M; Serrano M; Seta N; Sykut-Cegielska J; Thiel C; Tort F; Vals MA; Videira P; Witters P; Zeevaert R; Morava E
    J Inherit Metab Dis; 2019 Jan; 42(1):5-28. PubMed ID: 30740725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.